Haque M Azizul, Mizobuchi Teruaki, Yasufuku Kazuhiro, Fujisawa Takehiko, Brutkiewicz Randy R, Zheng Yan, Woods Kena, Smith Gerald N, Cummings Oscar W, Heidler Kathleen M, Blum Janice S, Wilkes David S
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
J Immunol. 2002 Aug 1;169(3):1542-9. doi: 10.4049/jimmunol.169.3.1542.
We have reported that lung allograft rejection involves an immune response to a native protein in the lung, type V collagen (col(V)), and that col(V)-induced oral tolerance prevented acute and chronic rejection. In support of these findings col(V) fragments were detected in allografts during rejection, but not in normal lungs. The purpose of the current study was to isolate and characterize col(V)-specific allograft-infiltrating T cells and to determine their contribution to the rejection response in vivo. Two col(V)-specific T cell lines, LT1 and LT3, were isolated from F344 (RT1(lv1)) rat lung allografts during rejection that occurred after transplantation into WKY (RT1(l)) recipients. Both cell lines, but not normal lung lymphocytes, proliferated in response to col(V). Neither LT1 nor LT3 proliferated in response to alloantigens. LT1 and LT3 were CD4(+)CD25(-) and produced IFN-gamma in response to col(V). Compared with normal CD4(+) T cells, both cell lines expressed a limited V-beta TCR repertoire. Each cell strongly expressed V-beta 9 and 16, but differed in expression of other V-betas. Adoptive transfer of each cell line did not induce pathology in lungs of normal WKY rats. In contrast, adoptive transfer of LT1, but not LT3, caused marked peribronchiolar and perivascular inflammation in isograft (WKY) lungs and abrogated col(V)-induced oral tolerance to allograft (F344) lungs. Collectively, these data show that lung allograft rejection involves both allo- and autoimmune responses, and graft destruction that occurs during the rejection response may expose allograft-infiltrating T cells to potentially antigenic epitopes in col(V).
我们曾报道,肺移植排斥反应涉及对肺中一种天然蛋白质——V型胶原(col(V))的免疫反应,并且col(V)诱导的口服耐受可预防急性和慢性排斥反应。为支持这些发现,在排斥反应期间的同种异体移植肺中检测到了col(V)片段,但正常肺中未检测到。本研究的目的是分离并鉴定col(V)特异性的同种异体移植浸润性T细胞,并确定它们在体内对排斥反应的作用。在将F344(RT1(lv1))大鼠肺移植到WKY(RT1(l))受体后发生排斥反应期间,从同种异体移植肺中分离出两条col(V)特异性T细胞系LT1和LT3。两条细胞系均对col(V)产生增殖反应,但正常肺淋巴细胞无此反应。LT1和LT3对同种异体抗原均无增殖反应。LT1和LT3为CD4(+)CD25(-),并对col(V)产生γ干扰素。与正常CD4(+) T细胞相比,两条细胞系均表达有限的V-βTCR库。每条细胞均强烈表达V-β9和16,但在其他V-β的表达上有所不同。每条细胞系的过继转移均未在正常WKY大鼠肺中诱导病理改变。相反,LT1的过继转移而非LT3的过继转移,在同基因移植(WKY)肺中引起明显的细支气管周围和血管周围炎症,并消除了col(V)诱导的对同种异体移植(F344)肺的口服耐受。总体而言,这些数据表明肺移植排斥反应涉及同种异体和自身免疫反应,并且在排斥反应期间发生的移植物破坏可能使同种异体移植浸润性T细胞暴露于col(V)中潜在的抗原表位。